The pentose phosphate pathway of glucose metabolism. Influence of a growth-hormone-secreting pituitary tumour on the oxidative and non-oxidative reactions of the cycle in liver.
1. Measurements were made of the activities of enzymes of the pentose phosphate cycle, glucose 6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, ribose 5-phosphate isomerase, ribulose 5-phosphate epimerase, transketolase and transaldolase, as well as of the related or competing enzymes glucokinase, hexokinase, phosphoglucose isomerase and phosphoglucomutase, in control rats and in rats bearing the growth-hormone- and prolactin-secreting pituitary tumour MtTW5, to study the effect of high endogenous concentrations of growth hormone on this pathway in liver. 2. There was a twofold increase in liver weight. Glucokinase activity/g. of liver decreased to half the control value in the experimental group, although on a total liver basis it remained unchanged. Hexokinase activity increased in parallel with the liver weight, so that the total activity was doubled in rats with a high endogenous concentration of growth hormone. No differences in response were found between heat-stable and heat-labile forms of hexokinase. 3. The activity/g. of liver of the two oxidative enzymes of the pathway decreased slightly in the experimental group, but this was offset by the increase in liver weight, and the resultant effect was a 50% increase in the total activity. 4. Of the non-oxidative enzymes of the cycle the most marked increase on a total liver basis was in ribose 5-phosphate isomerase activity, to 2.5 times the control value. Ribulose 5-phosphate epimerase activity showed the smallest increase. Transketolase and transaldolase activities were also increased. The latter is the rate-limiting enzyme of the non-oxidative reactions of the cycle in these animals. 5. The results are discussed in relation to the glycolytic pathway and synthesis of glycogen, and more particularly to the increased requirement for ribose 5-phosphate for RNA synthesis.
D000818:Animals; D005260:Female; D005941:Glucokinase / Q000032:analysis; D005947:Glucose / Q000378:metabolism*; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D013006:Growth Hormone / Q000502:physiology*; D006593:Hexokinase / Q000032:analysis; D007535:Isomerases / Q000032:analysis; D008099:Liver / Q000201:enzymology / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000378:metabolism; D010428:Pentosephosphates / Q000378:metabolism*; D010733:Phosphoglucomutase / Q000032:analysis; D010734:Phosphogluconate Dehydrogenase / Q000032:analysis; D010911:Pituitary Neoplasms / Q000378:metabolism*; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D014166:Transferases / Q000032:analysis
D010428:Pentosephosphates; D012313:RNA; D013006:Growth Hormone; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D014166:Transferases; D006593:Hexokinase; D005941:Glucokinase; D007535:Isomerases; D010733:Phosphoglucomutase; D005947:Glucose